NRC Earnings Nrc Health
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–52 of 52
| Q2 2026 | 2026-06-30 | -0.15 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.14 | 2026-05-06 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 49.58 | 2026-03-05 | 10-K |
| FY 2025 | 2025-12-31 | 50.00 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | 0.18 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.01 | 2025-08-08 | 10-Q |
| Q1 2025 | 2025-03-31 | 0.25 | 2025-05-09 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 0.27 | 2025-03-17 | 10-K |
| FY 2024 | 2024-12-31 | 1.04 | 2025-03-17 | 10-K |
| Q3 2024 | 2024-09-30 | 0.24 | 2024-11-08 | 10-Q |
| Q2 2024 | 2024-06-30 | 0.26 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | 0.27 | 2024-05-09 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 0.36 | 2024-02-27 | 10-K |
| FY 2023 | 2023-12-31 | 1.25 | 2024-02-27 | 10-K |
| Q3 2023 | 2023-09-30 | 0.32 | 2023-11-09 | 10-Q |
| Q2 2023 | 2023-06-30 | 0.29 | 2023-08-04 | 10-Q |
| Q1 2023 | 2023-03-31 | 0.28 | 2023-05-05 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 0.27 | 2023-03-03 | 10-K |
| FY 2022 | 2022-12-31 | 1.27 | 2023-03-03 | 10-K |
| Q3 2022 | 2022-09-30 | 0.33 | 2022-11-04 | 10-Q |
| Q2 2022 | 2022-06-30 | 0.33 | 2022-08-05 | 10-Q |
| Q1 2022 | 2022-03-31 | 0.34 | 2022-05-06 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 0.37 | 2022-03-04 | 10-K |
| FY 2021 | 2021-12-31 | 1.46 | 2022-03-04 | 10-K |
| Q3 2021 | 2021-09-30 | 0.38 | 2021-11-05 | 10-Q |
| Q2 2021 | 2021-06-30 | 0.35 | 2021-08-06 | 10-Q |
| Q1 2021 | 2021-03-31 | 0.36 | 2021-05-07 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | 0.32 | — | — |
| FY 2020 | 2020-12-31 | 1.45 | — | — |
| Q3 2020 | 2020-09-30 | 0.37 | 2020-11-06 | 10-Q |
| Q2 2020 | 2020-06-30 | 0.30 | 2020-08-07 | 10-Q |
| Q1 2020 | 2020-03-31 | 0.46 | 2020-05-08 | 10-Q |
| Q4 2019 (derived) | 2019-12-31 | 0.34 | — | — |
| FY 2019 | 2019-12-31 | 1.26 | — | — |
| Q3 2019 | 2019-09-30 | 0.31 | 2019-11-08 | 10-Q |
| Q2 2019 | 2019-06-30 | 0.29 | 2019-08-08 | 10-Q |
| Q1 2019 | 2019-03-31 | 0.32 | 2019-05-08 | 10-Q |
| Q1 2013 | 2013-03-31 | 0.64 | 2013-05-08 | 10-Q |
| Q4 2012 (derived) | 2012-12-31 | 0.53 | 2013-03-01 | 10-K |
| FY 2012 | 2012-12-31 | 2.17 | 2013-03-01 | 10-K |
| Q3 2012 | 2012-09-30 | 0.51 | 2012-11-07 | 10-Q |
| Q2 2012 | 2012-06-30 | 0.57 | 2012-08-10 | 10-Q |
| Q1 2012 | 2012-03-31 | 0.56 | 2012-05-11 | 10-Q |
| Q4 2011 (derived) | 2011-12-31 | 0.45 | 2012-03-01 | 10-K |
| FY 2011 | 2011-12-31 | 1.69 | 2012-03-01 | 10-K |
| Q3 2011 | 2011-09-30 | 0.39 | 2011-11-08 | 10-Q |
| Q2 2011 | 2011-06-30 | 0.34 | 2011-08-12 | 10-Q |
| Q1 2011 | 2011-03-31 | 0.51 | — | — |
| FY 2010 | 2010-12-31 | 1.26 | — | — |
| Q3 2010 | 2010-09-30 | 0.32 | — | — |
| Q2 2010 | 2010-06-30 | 0.25 | — | — |
| FY 2009 | 2009-12-31 | 1.26 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.